Understanding innovators' experiences of barriers and facilitators in implementation and diffusion of healthcare service innovations: A qualitative study by Barnett, J et al.
RESEARCH ARTICLE Open Access
Understanding innovators’ experiences of barriers
and facilitators in implementation and diffusion of
healthcare service innovations: a qualitative study
Julie Barnett1, Konstantina Vasileiou1*, Fayika Djemil2, Laurence Brooks1 and Terry Young1
Abstract
Background: Healthcare service innovations are considered to play a pivotal role in improving organisational
efficiency and responding effectively to healthcare needs. Nevertheless, healthcare organisations encounter major
difficulties in sustaining and diffusing innovations, especially those which concern the organisation and delivery of
healthcare services. The purpose of the present study was to explore how healthcare innovators of process-based
initiatives perceived and made sense of factors that either facilitated or obstructed the innovation implementation
and diffusion.
Methods: A qualitative study was designed. Fifteen primary and secondary healthcare organisations in the UK,
which had received health service awards for successfully generating and implementing service innovations, were
studied. In-depth, semi structured interviews were conducted with the organisational representatives who
conceived and led the development process. The data were recorded, transcribed and thematically analysed.
Results: Four main themes were identified in the analysis of the data: the role of evidence, the function of inter-
organisational partnerships, the influence of human-based resources, and the impact of contextual factors. “Hard”
evidence operated as a proof of effectiveness, a means of dissemination and a pre-requisite for the initiation of
innovation. Inter-organisational partnerships and people-based resources, such as champions, were considered an
integral part of the process of developing, establishing and diffusing the innovations. Finally, contextual influences, both
intra-organisational and extra-organisational were seen as critical in either impeding or facilitating innovators’ efforts.
Conclusions: A range of factors of different combinations and co-occurrence were pointed out by the innovators
as they were reflecting on their experiences of implementing, stabilising and diffusing novel service initiatives. Even
though the innovations studied were of various contents and originated from diverse organisational contexts,
innovators’ accounts converged to the significant role of the evidential base of success, the inter-personal and
inter-organisational networks, and the inner and outer context. The innovators, operating themselves as important
champions and being often willing to lead constructive efforts of implementation to different contexts, can
contribute to the promulgation and spread of the novelties significantly.
Background
The ability to innovate is considered as a major compe-
titive advantage in organisations, enhancing their effec-
tiveness, efficiency, and thus their potential for long
term sustainability [1]. The concept has been strongly
identified with manufacturing, where innovations con-
cern products and artefacts, while the service sector has,
by contrast, been seen as a “laggard” [2]. However, the
rapid expansion of the service sector in modern econo-
mies and the increasing “servicisation” of many, pre-
viously pure, manufacturing industries [3] have shifted
the focus of attention to new forms of behaviour and
activities, expressed as service innovations.
The healthcare domain, and its ability to implement
and diffuse innovations has generated intense scientific
interest (for reviews see [4,5]). The need for innovation
in service delivery and organisational functions has been
emphasised since the early 1980s [6]. Nevertheless,
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healthcare systems in developed countries continue to
encounter considerable difficulties in implementation,
and experience major delays in diffusing novel initia-
tives, despite the perception that healthcare organisa-
tions are arguably among the most knowledge-rich and
scientifically-based institutions [7].
The imperative to innovate in healthcare has recently
intensified under the economic challenges and the
increasing demands of an ageing population. In the UK,
this has resulted in calls for reform of the National
Health Service (NHS), recently crystallised in the Equity
and Excellence: Liberating the NHS White Paper [8].
This aligned healthcare policy around the Quality, Inno-
vation, Productivity, and Prevention (QIPP) programme
initiative with the redesign of health services aimed at
improving quality while making significant efficiency
savings. The notion of innovation occupies a core posi-
tion within this reformed policy framework now placed
at the heart of the healthcare agenda.
Conceptualising healthcare innovations
Innovation can be defined as “the intentional introduc-
tion and application within a role, group or organisation
of ideas, processes, products or procedures, new to the
relevant unit of adoption, designed to significantly bene-
fit the individual, the group, the organisation or the
wider society” [9] (p.209). Anderson et al. [10] suggest
that this definition presents several advantages: firstly, it
demarcates innovation from creativity, secondly, it con-
ceptualises innovation as a deliberate effort, aiming at
benefit, and thirdly, it highlights the relativity of novelty.
Following this definition, Länsisalmi et al. [5] suggested
that healthcare innovations typically comprise “new ser-
vices, new ways of working and/or new technologies” (p.
67). These novelties “are directed at improving health
outcomes, administrative efficiency, cost effectiveness, or
users’ experience and are implemented by planned and
coordinated actions [4] (p.582). Healthcare innovations
constitute particularly complex outputs, since they fre-
quently combine both product and process novelties, or
embodied and disembodied components [11] with diver-
sified levels of materiality or tangibility.
Theoretical perspectives in healthcare innovation research
A large body of research on healthcare innovation has
been strongly influenced and shaped by Rogers’ seminal
work on diffusion of innovation [12]. Within this
approach, healthcare innovations are adopted and dif-
fused more easily when certain conditions are favour-
able. For example, the perceived relative advantage, the
potential to trial and observe the effects of the innova-
tion, and its compatibility with the values, norms and
beliefs of the adopting system are all believed to facili-
tate the diffusion [13]. Furthermore, innovations are
more likely to spread when they are consistently sup-
ported by key opinion leaders and when homogenous
groups of people sharing common values are involved.
Social networks and inter-organisational partnerships
are also recognized as highly significant forces [13-15].
Other theoretical approaches propose a more complex
and often turbulent process of innovation diffusion that
follows “a nonlinear cycle of divergent and convergent
activities that may repeat over time and at different
organizational levels”[16] (p.16). For example, research-
ers have studied the impact of scientific information on
the diffusion of healthcare innovations [17-19] and have
found that robust scientific evidence does not necessa-
rily lead to innovation adoption in a linear or direct
way. The relative advantage of healthcare innovations,
and even the evidence of benefit, is not a judgement
rooted in pure rationalistic reasoning, but rather is sub-
ject to debate and negotiation. This is partly linked to
multi-professionalism [20] characterising healthcare
where the different professional groups adhere to and
value different types of evidence, and also to the
demands stemming from the context in which evidence
is embedded and interpreted [21].
Finally, adopting a more systemic approach the theory
of disruptive innovation [22,23] has also been proposed
as a conceptual framework to enhance our understand-
ing concerning the difficulty the healthcare systems have
to lead and sustain innovation. According to this theory,
disruptive technological advancements in healthcare are
not embedded in corresponding business-model innova-
tions which would allow healthcare organisations to
take full advantage of these technological enablers and
to deliver ‘pure’ value propositions to their users. This
happens because healthcare organisations, structured
historically in the form of hospitals and physicians’ prac-
tices, conflate fundamentally different business models.
For disruptive innovations to become embedded in
healthcare, several factors need to be aligned including
suitable business models and regulatory reform while
the inherent technological characteristics of the change
and specifically, its ability to simplify are also critical
[22,23].
The aims of the present study
This study sought to shed further light on the question
of process-level innovation and to understand more
about why diffusion is apparently so poor in healthcare.
By interviewing award winners of service innovations,
we sought to understand innovation from inside the
organisation by exploring the perspectives of those who
drive it. Technology was not excluded from these case
studies but accommodating a new technology was not
the principle driver for innovation. Specifically, we were
interested in examining how healthcare innovators
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perceived and made sense of their experiences of factors
that facilitated or constrained their success. We adopted
a critical realist perspective [24] which allowed us to
consider how these factors were constructed and inter-
preted in innovators’ accounts. A qualitative study, with
semi-structured interviews, was conducted among NHS
employees highly engaged with particular innovations.
Methods
Sample and recruitment strategy
Healthcare organisations in the UK, which had gener-
ated and implemented service innovations and whose
efforts had been recognized through an award, were the
study population of this research. Specifically, primary
and secondary healthcare organisations who were win-
ners of Health Service Journal (HSJ) [25] awards from
2007 to 2009 were invited to participate. The HSJ is the
premier weekly journal read by NHS managers and
healthcare professionals with a print circulation of
17.680 copies [26]. The organisations submitted an
application for inclusion in the contest, and following a
favourable assessment, presented their cases to a panel
judges in a face-to-face presentation, following which
final decisions were made. In this way, we secured a
measure of innovation that was external-to-the-innova-
tors and which provided a relatively comparable metric
of their success. HSJ awards reasonably affirmed a suc-
cessful implementation status, at least within a single
organisation. Additionally, winning these awards indi-
cated that these innovations were valued positively
within the NHS system, and that broader adoption
would be judged as desirable. Moreover, a variety of ser-
vice innovations with different aims and from diverse
contexts were targeted; all initiatives were process-
based, even though product-based innovation was some-
times part of the overall initiative.
Fifty-one organisations (20 primary care organisations,
30 secondary care organisations, and 1 educational insti-
tution in collaboration with the NHS) of HSJ service
innovation awards were approached and informed about
the study. Twenty four of these expressed an interest in
knowing more, and of these 15 agreed to take part in
interviews (response rate: 29.41%). Table 1 summarises
the participating innovations, providing a short descrip-
tion and the award title for each of them. The classifica-
tion of the innovations presented in table 1 was
developed by the researchers based on the key theme of
the innovations and their relationship to the main func-
tion of the NHS system, namely the provision of health-
care. Among the participating organisations, 5 provided
primary care and 10 secondary care. Thirteen out of
23 HSJ award categories are represented in our sample
(see table 1), while the following are not: 1. Acute Health-
care Organisation of the Year, 2. Chronic Disease
Management, 3. Communications, 4. Cost Effective Part-
nership, 5. Implementing NICE Guidance, 6. Informa-
tion-based Decision Making, 7. Patient Safety, 8. Primary
Care Innovation, 9. Reducing Health Inequalities, and 10.
Data-driven Service Improvement.
Finally, the people interviewed were directly engaged
with the service innovation; in most of the cases, they
had been involved with generating the initial concept
and had led the processes of implementation and diffu-
sion. All interviews were conducted with one innovator,
except for one case (Good Corporate Citizenship; see
table 1) where four interviewees took part since they all
had contributed to different aspects of the innovation.
As the focus of our research was on examining a range
of service innovations rather than seeking different per-
spectives around the same innovation, we chose only to
interview a single key informant around each innovation
and as part of the interview explored the role attributed
to others in directly or indirectly contributing to its
implementation and diffusion.
Data collection and ethical considerations
Semi-structured telephone interviews, lasting around 45
minutes, were conducted at scheduled times during Sep-
tember-October 2010 with key representatives of the
healthcare service innovations. Initially, people were con-
tacted by e-mail, informed about the aims of the study
and invited to take part in a telephone interview. Pro-
spective interviewees were provided with an information
sheet explaining the aims, procedure and ethical aspects
of the project, as well as the consent form in which they
confirmed their willingness to participate. Latterly, inter-
viewees were able to indicate their agreement with the
information disclosed and the validity of our analysis (i.e.
testimonial validity [27]) in a pre-publication draft paper.
Interviews included questions about the generation
and development of the service innovation, the barriers
and facilitating factors experienced, and the wider
uptake of the innovation. Rather than directing the
interviewees to discuss specific themes previously identi-
fied in the literature, we deliberately created open-ended
questions. This allowed the interviewees to pick up
spontaneously on those factors that were perceived as
most important for their innovation and then they were
prompted to discuss the issues in more depth. More
specifically, the interview schedule was comprised of the
following questions:
A. Conception and development of the innovation
Could you please tell me about (name of the
innovation)?
Where did the idea come from?
Can you tell me about the process of developing this?
How much opposition/interest did you meet along the
way?
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How was the service innovation viewed by your orga-
nisation/in your local context? Did that change at all
over time?
B. Diffusion of innovation
Has your innovation been picked up by others?
How did this come about?
What have they done with it?
What do you think were the main reasons for their
interest?
C. Perceived barriers and facilitators of innovation
diffusion
What factors do you think have encouraged/con-
strained its uptake by others?
What do you think are the main reasons for this?
How could this have been different?
Participants also provided information about their role
in the organisation and the innovation process as well
as their participation in the actual HSJ competition. The
Table 1 Classification, award titles, and descriptions of innovations
Innovations directly related to healthcare provision
Categories Award titles Short description
I. Innovations of specified healthcare
provision
1. World Class
Commissioning
1. Initiative that developed a timely and coordinated hyper-acute service provision
to stroke patients with early care and fast access to services, and educated
organisations to implement stroke care according to national guidelines
2. Clinical Service
Redesign
2. Initiative that redesigned the acute stroke service offering rapid assessment and
care provision, and rehabilitation closer to home
3. Mental Health
Innovation
3. Initiative that provided evidence-based interventions to chronic respiratory
patients helping them to manage their synchronic mental health conditions (e.g.
depression)
4. Best Social
Marketing Project
4. Initiative that targeted pregnant women to access smoking cessation services,
designed on the basis of their needs
II. Innovations related to the overall
organisational function
1. Primary Care
Organisation of the
Year
1. Initiative that concerned a variety of organisational functions, from several health
care provision programmes and sound financial management, to the development
of local partnerships and the positioning of the organisation as a leader
III. Innovations related to patients’
safety*
1. Acute & Primary
Care Innovation
1. A reliability checklist that ensured the conduction and revision of appropriate
medical checks in round-wards
2. Improving Care
with Technology
2. A technologically-based innovation that secured adherence to evidence-based
guidelines during the blood transfusion process, reducing errors/omissions,
paperwork, process time per patient and staff capacity requirements
IV. Innovations of patients’ access and
reception of healthcare
1. Improving Patient
Access
1. Initiative that improved prisoners’ access to healthcare services through their
involvement and the development of the scheme of “prisoner healthcare
representatives”
2. Patient Centred
Care
2. Initiative that applied a patient-centred model of care giving patients choice,
involvement and control over their care experience
V. Innovations of educational services 1. Mental Health
Innovation
1. A training programme that educated professionals in evidence-based family
interventions, increasing their awareness to the needs of carers of mentally ill
patients
2. Skills Development 2. A training programme that educated diabetes diagnosed patients to better self-
manage their condition and provided continued professional development to
trainers and educators.
Innovations less related to healthcare provision
Categories Award titles Short description
VI. Innovations related to human
resources
1. Recruitment &
Retention
1. A human-resources and workforce development initiative that reformed the
recruitment and retention practices through the provision of training programmes
and employment opportunities to local unemployed and excluded groups
2. Workforce
Development
2. A workforce transformation programme that prepared staff to provide care
closer to home
VII. Innovations related to other
organisational functions (e.g. logistics)
1. Good Corporate
Citizenship
1. Initiative that introduced a transportation scheme, IT developments and new
methods of food procurement and waste management which increased
organisational sustainability and supported the local economy
2. Best Social
Marketing Project
2. Initiative that provided free access to leisure facilities to disadvantaged groups of
citizens in collaboration with the city council
* Technological products were incorporated
Barnett et al. BMC Health Services Research 2011, 11:342
http://www.biomedcentral.com/1472-6963/11/342
Page 4 of 12
study received ethical approval from the Research Ethics
Committee of Brunel University London.
Analytic procedure
A thematic analysis, informed by a critical realist stance
[24] was conducted on the transcribed interviews. A cri-
tical realist epistemological position offers the possibility
of accounting for the ways in which the social world is
constructed through language, whilst simultaneously
recognizing the existence of an external-to-discourse
reality. This reality is constituted by the material and
institutional world and is considered to influence the
meanings and the discourses which people invoke to
construct the objects at stake [28]. The employment of
a critical realist perspective allowed us to locate innova-
tors’ experiences within the broader material and insti-
tutional contexts they operated.
Thematic analysis was considered to be an appropriate
technique identifying as it does, “repeated patterns of
meaning” across a set of data [29,30] (p.86). An induc-
tive approach with a full presentation of themes was
selected and the data were analysed semantically,
emphasising the explicit meaning of the themes. In
addition to description, an interpretation of the themes
is provided.
There were four stages in the analysis. Initially, there
was a familiarisation process with the data; then, an
initial coding took place, where particular extracts were
named and defined. Next, themes and subthemes were
developed by aggregating the respective coded segments.
The construction of the comparative analytical cate-
gories was assisted by the use of computer software
[31]. Finally, the themes and subthemes were revised
and refined, ensuring that the criterion of internal
homogeneity and external heterogeneity [32] was met
satisfactorily, and that the themes reflected the data.
Initial coding of the data was applied by KV, and the
themes and sub-themes were developed, revised and
refined by JB and KV.
Results
Four themes were identified in the analysis and are pre-
sented in the following sections: (a) the role of evidence,
(b) the role of partnerships, (c) the influence of cham-
pions and other human-based resources, and (d) the
impact of contextual factors both organisational and
external. All of these played a role, alone or in combina-
tion, to facilitate or block implementation or diffusion
of the innovation.
(In order to protect the participants’ anonymity, as
they are drawn from a narrow range of award years,
after each quote below, the innovation is identified by
the extent to which it is related to the healthcare provi-
sion-see Table 1 for the relevant categorisation).
A. The role of evidence
Evidence was considered to play a crucial role. This was
visible at multiple time points in the initiation, imple-
mentation and diffusion of service innovations. Specifi-
cally, there was a focus on quantitative evidence and
this was seen to operate in three main ways: (a) as a
proof of effectiveness, (b) as a means of diffusion and
(c) as a precondition for the initiation of the innovation.
A1. Evidence as a proof of effectiveness
“Hard” evidence, in the form of quantitative data, was
perceived as the ‘gold standard’ demonstration of effec-
tiveness, constituting an optimal and credible base for
assessing an innovation. It equipped innovators to attest
to the usefulness and success of their initiatives, and to
persuade prospective adopters that they were valuable.
A participant characteristically commented:
“So our outcomes are important to us, because they
give us sort of a language by which we can sort of
articulate the success of it.” (Innovation less related
to the healthcare provision)
Even when the innovators considered that “soft”
aspects of the impact were valuable and significant for
the demonstration of usefulness, they also attempted to
corroborate this with numerical evidence. The latter
represented the indisputable metric needed to buttress
accounts of “soft outcomes”.
“All the guys that work for me work for nothing,
and the job satisfaction of seeing these guys change
and...build confidence...is just absolutely amazing,
and I think, if nothing else, if people want to call it
soft outcomes-I mean, we have got figures of how
we’ve improved stuff, you know...I can give you
some statistics on that, on how we’ve improved stuff
in 2009.” (Innovation directly related to the health-
care provision)
Lack of quantitative evidence was seen as a notable
shortcoming not only for the sustainability and diffusion
of the innovation but also for its initiation. This percep-
tion was particularly pronounced where there were
other barriers and when the initiative was peripherally
linked to the core business of the NHS. In such cases,
quantitative evidence that would link the innovation to
health-related outcomes was imperative.
“One of the things which we need to expand is the
health impact of schemes like this (social inclusion
schemes), whilst we have a lot of anecdotal evidence
we need to gather empirical evidence to demonstrate
the long term benefits. In an increasingly challenging
fiscal climate, supporting evidence may encourage
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organisations to make the investment in this type of
development.” (Innovation less related to the health-
care provision)
Within certain professional groups, almost notably clini-
cians, “hard” evidence which would be obtained from
scientific methods was construed as the necessary prere-
quisite for the demonstration of the innovation impact,
without which any persuasive effort was doomed to failure.
Anecdotal or experiential testimonies were unable to exert
any significant influence; scientific data were seen as the
only basis for a process of persuasion, and on which pro-
spective adopters could make informed decisions.
“For some reason, with doctors, if you haven’t got
some data, and maybe a p-value, then it’s really hard
to convince them that something works. What we’ve
found it is, if we just give it to people and tell them
it’s a good idea, they don’t believe us; whereas, if we
give it to people and we show them our chart, where
we can show that, when we use the checklist, we
have a massive change, and suddenly we’ve got a p-
value, that seems to win hearts and minds.” (Innova-
tion directly related to the healthcare provision)
A2. Evidence as a means of diffusion
“Hard” evidence was also a sound means of dissemina-
tion, both intra-organisationally and inter-organisation-
ally. Encouraging health outcomes based on empirical
data led organisations, in some instances, to propose the
adoption of innovation to other departments. Moreover,
the availability of evidence enabled innovators to neutra-
lise resistance and opposition.
“...So instead of taking an aggressive approach to
that, we backed it up with data...So we simply just
sent the audit data round, which picked up a few
people.” (Innovation directly related to the health-
care provision)
Similarly, evidence was seen to help innovators obtain
human and financial resources needed to expand geo-
graphically and inter-organisationally.
“...and then we actually audited the results of their
intervention...and actually evidenced that the team
were having an effect on patients’ wellbeing, and
that led to the team being enhanced staff-wise, and
the service then rolling out city-wide.” (Innovation
directly related to the healthcare provision)
A3. Evidence as a precondition
Quantitative data were often seen as a base and precon-
dition for the initiation of the innovation, indicating the
need for change or the scope for benefit. Pre-existing
evidence, which was available before the initiation of the
innovation, was used to argue, justify and bolster the
case for the developing initiative and it clarified innova-
tors’ incentives and intentions, particularly when resis-
tance was anticipated. In this way, uncertainty was
reduced and the stakeholders involved could estimate
the potential risks and benefits.
“I personally was surprised that there wasn’t more
opposition really to closure than that, but I think
people were genuinely, staff included, genuinely con-
vinced by the evidence supporting why this was the
right move and what it would mean.” (Innovation
directly related to the healthcare provision)
B. The role of partnerships
Inter-organisational connections, either formalised as
partnerships or loosely linked, constituted an integral
part in the process of developing, establishing and dif-
fusing the innovations. In some instances, the partner-
ships were seen to be part of the essence of the
innovation itself.
Existing working relationships between partners’ orga-
nisations were often identified as the starting point of
the innovation and the driving force for its development.
Trust and mutual support were vital prerequisites for
cooperation, since they ensured that the decisions and
commitments made would be adhered to by all parties.
The importance of trust was amplified when there was
high uncertainty around what would follow.
“But I think why it worked for us was that we had a
combination of a good working relationship in an
environment where the decisions could be made by
those people, so you already had some trust, you
already had confidence that partners were going to
pull their weight...I mean what the PCT [Primary
Care Trust] didn’t know was whether people would
come and use their offer, but what they did know was
that if they gave the city council in our area the
money, we’d do with it what we said we’d do with it.”
(Innovation less related to the healthcare provision)
The building of partnerships was a goal of innovators
in their attempt to initiate and establish their services,
and the lack of them was often assumed to be a reason
for failure of previous initiatives, even when these might
be well supported financially. The quote below illus-
trates this point.
“Then, as we were looking around, we realised we
hadn’t really got any formal links with other
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services...and actually, whilst we’d got a good level of
resource going into the [name of previous service],
we weren’t getting the impact that we wanted. So,
that’s where it started from.” (Innovation directly
related to the healthcare provision)
Having built supportive partnerships, the innovation
gained more chances of sustainability in the long term,
since partners represented a securing mechanism, war-
ranting and endorsing the continuation.
Dissemination of service innovations was also seen to
be contingent upon partnerships. Partners who had an
interest in the novelty were perceived as significant in
promoting and publicising the message beyond organi-
sational boundaries.
“...and we’ve got some very good relationships with
voluntary organisations anyway, but to just obviously
build on that, do more promotions out in the com-
munity, working with organisations in obviously pro-
moting what we’re doing and how that could fit into
the outside world.” (Innovation directly related to
the healthcare provision)
Importantly, partnerships were sometimes seen as one
of the beneficial side-effects that enabled people to con-
struct a common communication framework and a
mutually shared agenda, potentially useful for future
interactions and collaborations. Interestingly, in some
instances the emergent partnerships themselves were
identified as a novel characteristic of the service, usually
when the collaborations were believed to be exceptional
and rare in the field of healthcare.
“It is the process and, you know, great credit to the
PCTs across [city name] to agree to work together.
That isn’t the same in lots of other areas. And so the
structures that were put in place and the way that
they worked closely with the clinicians and the wider
stakeholder group certainly was innovative.” (Innova-
tion directly related to the healthcare provision)
Finally, and in retrospect, success was perceived to
have been unlikely without the a priori consensus of the
involved partners. Proactive engagement and dialogue
were vital because organisations had the opportunity to
agree on the principal elements of the initiative, and in
turn the perceived risks were minimised, the undertak-
ing was legitimised and the partners were committed to
support the initiative and to follow the rules.
“...I think, you know, because we had great stake-
holder engagement, and we’d started off with a big
consensus event where we’d agreed some basic
principles that we would abide by, then I think
everybody felt comfortable.” (Innovation directly
related to the healthcare provision)
Proactive engagement with partners was also seen as
an effective strategy against future resistance and able to
mitigate potential obstructions, particularly when the
innovation was perceived to be radical and to diverge
significantly from the existing norms.
“So we knew that we’d have to come up with some-
thing completely different, so we engaged key stake-
holders at the outset... because we involved them at
the beginning we didn’t receive any opposition.”
(Innovation directly related to the healthcare
provision)
C. People-based resources
People within and outside the organisations were per-
ceived as particularly significant, either in facilitating or
inhibiting the innovation journey.
Most interviewees highlighted the importance of
champions, who could be employees in various organi-
sational positions, people in the local community or the
users of the innovation. Importantly, the innovators
themselves, in being passionate about and committed to
their initiatives, ultimately became champions.
The role of top and senior management was critical,
since the financial support of the initiative, and thus its
sustainability and success, was often contingent upon
their decisions. Public espousal of the core ideas of an
innovation was also represented as a key resource, able
to transfer new knowledge necessary for the advance-
ment of the initiative. The interviewee below, comment-
ing on the significance of champions, said:
“It is important. We’re fortunate, we’re led from the
top, our Chief Executive and our Chairman are very
passionate, as are our Trust Board, about sustainabil-
ity. We’ve also got an environmental awareness cam-
paign that we started again in the New Year that’s
just gone. We’ve now got 147, I think it is, environ-
mental champions across the Trust, that are driving
it forward, and we’re recruiting all the time. These
are obviously voluntary posts, but the passion and
the commitment out there is absolutely fantastic. So
I don’t think it would stop. I think it would take it
to new levels, because people are bringing in things
that we’ve never even thought of.” (Innovation less
related to the healthcare provision)
The users of the novel services could also constitute
powerful champions, as they were able to circulate their
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experience to the local community, thus promulgating
the new service and counteracting possible resistances.
“The students themselves who have come through
the Academy have demonstrated behaviours which
are exemplary and they have been the greatest advo-
cates for the Academy,-the reputation of the Acad-
emy has allowed it to grow, we do still have people
who are anti the Academy, which is reflective of
working with excluded groups, but we have far more
supporters.” (Innovation less related to the health-
care provision)
Employees were seen as a vital channel for intra-
organisational and inter-organisational diffusion, since
they can persuade their colleagues informally or influ-
ence decisions directly, especially when they occupy
key positions. They were considered as powerful advo-
cates when they experienced beneficial results in their
daily working routines and regarded the innovation as
advantageous. By contrast, employees affected nega-
tively can put up barriers that require effort to sur-
mount through proactive engagement and timely
information provision.
“...the way that we did that was to just start off with
very small pilots in non-acute areas, and develop a
process which was so much better for the nursing
staff that they were, you know, they were so
delighted to have it that they would, you know, they
would work with us and become advocates for us
when we went to new clinical areas.” (Innovation
directly related to the healthcare provision)
Barriers to the implementation and diffusion of inno-
vations were perceived to arise when the innovators and
the decision-makers belonged to different professional
groups. Different educational backgrounds, organisa-
tional roles, and diverse worldviews resulted in different
priorities, which could delay or obstruct the spread of
innovation. In such cases, innovators had to devote
much effort to persuading decision makers of the useful-
ness of the initiative.
“...sometimes the people who are in charge of the
budgets are not necessarily very familiar with clinical
priorities. So they might be somebody who’s actually
an accountant, who’s responsible for helping the
PCT decide which disease areas and which services
to put their money in. So you have to...be prepared
to almost educate people about why what you’re
doing is important.” (Innovation directly related to
the healthcare provision)
D. Contextual factors
The context, both intra-organisational and extra-organi-
sational, was also perceived to decisively influence the
life-cycle of the healthcare innovations.
D1. Intra-organisational context
three basic subthemes were identified, relating to: (a)
organisational receptiveness, (b) available resources, and
(c) organisational capability to promote the innovation.
a. Organisational receptiveness A series of long-term
changes often preceded implementation of the service
innovation, especially when the latter was large-scale
and system-wide. These changes were believed to pre-
pare the organisation structurally and functionally to
receive the novelty smoothly, especially when the
impending initiative was complex and multifaceted. In
this case, the process of implementation and spread was
constructed as an incremental change, embedded in an
already changing system.
“...we’d been developing our pathway for stroke and
aspects of it, year on year, since 2000, and I think it
was that foundation that truly enabled us to respond
in the way that we did and deliver that [innovation].”
(Innovation directly related to the healthcare
provision)
Organisational culture was also perceived to be a criti-
cal factor. Specifically, the openness of the organisation
to trial new ideas and carry the associated risks was
seen as significant, particularly when the change was not
triggered by external factors, such as policy initiatives,
or an obvious and urgent organisational need.
“...there was an environment of being prepared to
take a risk, with the right kind of conditions to sup-
port that.” (Innovation less related to the healthcare
provision)
Equally important for diffusion was the fit between the
innovation and the organisational ethos. When innova-
tors’ values were perceived to be congruent with prevail-
ing organisational norms and beliefs, the diffusion was
facilitated, since the novelty affirmed the cultural organi-
sational orientation. By contrast, when the innovation
collided with basic organisational principles, resistance
emerged and dissemination was impeded.
“You know, it’s just changing-it’s a big culture
change, and it does meet with controversy and it
does meet with people who still feel that prisoners
shouldn’t have any rights at all, and so you are con-
stantly coming up against that.” (Innovation directly
related to the healthcare provision)
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b. Available resources Sufficient human and financial
resources were of paramount importance not only for
the proper implementation of service innovations but
also for their diffusion to other organisations, sectors
and fields of practice. Shortage of resources, or fear of
this, could block innovators’ efforts and led to stagna-
tion. An interviewee, employing the metaphor of
“paralysis”, commented:
“It’s very clear what we need to do in stroke, and
sometimes, just the paralysis is just that the money
isn’t there to develop early supported discharge.”
(Innovation directly related to the healthcare
provision)
c. Organisational capability to promote the innova-
tion Innovators’ own capability to promote their initia-
tives within and beyond their organisation was
considered to facilitate diffusion. Specifically, awards,
media attention and the possibility of academic publica-
tions were viewed as a powerful means of communicat-
ing the innovation to the wider publics.
“When we got that far, and, crucially publicised what
we’d been doing-enter awards, produced journal
publications-which was very helpful to us. You
know, having the picture of the process on the front
page of the premier international transfusion journal,
things like this.., trying to develop some momentum
behind it.” (Innovation directly related to the health-
care provision)
Winning awards was experienced as a crucial social
recognition in three main ways: firstly, awards were per-
ceived as an external and unbiased validation of the
innovation, against which it was difficult for doubters to
argue. Secondly, awards were seen to raise the profile of
organisation and its reputation of being innovative,
which in turn helped it to build further networks and
inter-organisational collaborations. It also identified the
organisation as an early adopter. Thirdly, innovators
regarded the awards as an effective means of promoting
an agenda, which in turn could attract further resources.
“...if you do have a good profile nationally, regionally,
things come to you. You know, you are invited to
participate in things, to be early adopters and, that’s
for the benefit of the people that we serve really, so
it’s not just about the glory-it’s about being at the
table...” (Innovation directly related to the healthcare
provision)
Active promotion of the innovation with other organi-
sations was presented as essential and innovators
believed that they should communicate and publicise on
an on-going basis. In this way an extrovert organisa-
tional culture is cultivated. This sharing-behaviour
enabled innovators to identify pitfalls and advise pro-
spective adopters of the most promising ways of imple-
mentation.
“You know, that’s one of the big ethos behind kind
of the networks really is, it’s around sharing. It’s not
about keeping it to yourself. It is definitely around
sharing good practice, sharing what’s learnt, and
also, hopefully things that went wrong for us, shar-
ing that as well and saying this is how...don’t do
that, don’t go down off that road because we tried
that and it didn’t work, as much as it is about saying
this route worked really well.” (Innovation directly
related to the healthcare provision)
Innovators recognised that diffusion would involve
adaptation to the new context. “Re-invention” [12]
rather than replication was seen as an imperative for
prospective adopters. In the context of complex organi-
sational settings, interviewees stressed that to “survive”
and be successful was only possible if necessary adapta-
tions and adjustments were made.
“And also everybody, to some extent, has to evolve
these things for their own circumstances, don’t
they?....It’s not a one-size fits all.” (Innovation
directly related to the healthcare provision)
D2. Extra-organisational influences
Three main external influences were identified in inno-
vators’ accounts: (a) economic, (b) political, and (c)
ideological.
a. Current economic climate The constrained eco-
nomic climate was often cited as inhibiting initiatives
which were expensive and did not save costs directly.
Such innovations were unlikely to attract funding and
sustained financial support, since they were seen to
oppose the measures needed in challenging economic
conditions.
“I think we did it at exactly the right time, because I
think, now, it’s quite a difficult time in terms of
obviously, the economic climate. It’s really difficult
in terms of funding that’s available, and actually,
there needed to have been some pump-priming
upfront to be able to deliver this.” (Innovation
directly related to the healthcare provision)
b. Political influences Politics was constructed both as
a positive and a negative force in diffusion efforts. In
terms of benefit, the presence of regulatory bodies that
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would shape practices around specific innovations was
considered to facilitate certain initiatives. Conversely, it
was more problematic where there was a more fragmen-
ted landscape of accountability and no clear responsible
body to align stakeholders’ activities.
“The problem is, there is actually no national body,
as I said again, responsible for food. If you ring the
Department of Health and say “Who’s responsible
for food in the NHS?” you’ll get a complete blank.”
(Innovation less related to the healthcare provision)
Additionally, when the innovation was believed to
entail political risks or ran against the dominant political
forces within the local context, the diffusion met severe
challenges.
c. Ideological influences The last critical factor for suc-
cess was the perceived fit of the innovation with the
broader ideological context, both within and outside the
healthcare sector. When an innovation was viewed to
reflect dominant ideological beliefs and to be consistent
with the “spirit of the times”, initiatives were more likely
to become established. This was especially so for those
innovations which were peripherally linked to the core
function of the NHS. In this case, innovators had to
resort to ideological resources external to the domain of
healthcare, such as environmentalism, in order to
endorse the value of their initiatives.
“I was going to say this is a really good period of
time to be doing these things because there is a gen-
eral awareness, there are all sorts of things that the
Trust has to do in saving energy. People think it’s a
good idea. The community thinks it’s a good idea. It
costs you if you don’t.” (Innovation less related to
the healthcare provision)
Discussion
This study sought to examine the subjective experiences
and interpretations of factors facilitating or blocking the
implementation and diffusion of process-based health-
care innovations. It did this by exploring innovators’
own accounts of these processes. Overall, our results eli-
cited themes commonly found in the literature of inno-
vation diffusion, echoing previous studies [33,34].
Significantly, the notion of evidence consistently
emerged as the key leitmotif in narratives of the innova-
tion journey. The development of social networks, both
inter-personal, expressed through champions and advo-
cates, and inter-organisational, was an additional critical
theme, while both the immediate organisational context
and the wider socio-political and economic environment
were recurrently articulated as major influencing factors.
Evidence was constructed as a powerful parameter
that provided innovators with a sound base for their
own assessment in turn allowing the initiation and diffu-
sion of innovation. Evidential knowledge constituted a
transparent, unbiased and credible source, from which
innovators could extract their arguments and could
structure their persuasive efforts in terms of innovation
utility and effectiveness. As May et al. [35] suggested
“evidential knowledge serves a stabilising purpose for
ideational claims” (p. 703). The desire for “hard” or
numerical evidence dominated. This was evident, not
simply around those innovations which were more clini-
cally-oriented but was also considered vital for innova-
tions less centrally-related to healthcare provision or led
by non-medical staff. Here too numerical or financial
descriptors were aspired to; they provided ideal metrics
for indicating the impact of the innovation. Importantly,
a polarisation was observed with innovators often con-
trasting numerical evidence with experiential testimonies
or anecdotal evidence, while the potential for a rigorous
qualitative assessment of the value of the initiative was
absent from peoples’ accounts. The strong reliance on
quantification and the accompanying disregard of
experiential knowledge is reflective of the pursuit of
objectivity. Quantitative data and the highly structured
rules for producing this have been rendered as a power-
ful tool for conferring trustworthiness to knowledge
claims, appearing exempt from subjective judgments
and local singularities [36].
Although evidence was depicted as a powerful tool
from the innovators’ point of view, they did not claim
that the evidence they had assembled were necessarily
the most accurate or reliable metrics of innovation
effectiveness or consider that it would be uncontested
and readily acceptable among a broader range of stake-
holders. Indeed, the innovators were often aware of the
weaknesses or deficiencies of their approach and
expressed a desire for more or stronger evidence [Vasi-
leiou, Barnett, Young, unpublished data]. The evidence
they were able to collect and produce seemed enough to
convince immediate stakeholders but how compelling it
was considered to be for a broader audience was much
more questionable.
Arguably, the ubiquitous preoccupation with evidence
reflects the strong profile of the “evidence-based prac-
tice” movement within healthcare sector since the early
1990s [37]. Though deriving from the medical commu-
nity, our findings suggest that representations of evi-
dence-based practice and of its value have been
assimilated by other professional fields within health-
care. The sort of evidence perceived as adequate and
thus persuasive varied considerably across the profes-
sional memberships of innovators, with medical staff
espousing almost exclusively scientifically derived
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evidence, while other professionals contented themselves
with statistics and financial figures. However, conviction
concerning the necessity, transparency and objectivity of
empirical data for the audit of innovations was common
to all. Ultimately, evidence was constructed as the tool
which would legitimate an unproblematic and direct dif-
fusion of innovations within a sector that traditionally
relied on scientific knowledge. Other sources of knowl-
edge, such as experience, would fail to do so especially
under the burden of uncertainty and risks that any orga-
nisational change embodies. Consequently, evidence
constituted a stable and substantial reference point from
which arguments of innovation utility could be justified
and practices of persuasion could be initiated.
Several types of inter-organisational links (e.g. struc-
tural, administrative, institutional, or resource links)
have been conceptualised as antecedents of organisa-
tional innovativeness [14]. In this study partnerships
were not only seen as a prerequisite of innovation, but
also as a result of innovation; inter-organisational links
were part of the essence of the innovation itself. This
was highly valued and constructed as an important
“legacy” for the local community.
Our findings suggest that inter-organisational links
served two important and complementary purposes:
material and symbolic. Materially-based partnerships
provided the innovative organisation with the necessary
resources, required for the implementation and diffusion
of initiatives. Symbolically, inter-organisational
exchanges allowed organisations to gain local consensus
and therefore to bolster the new service with legitimacy.
Particularly when innovations were perceived to be radi-
cal, proactive engagement with various stakeholders was
common. Consequently, inter-organisational collabora-
tion was not only seen as vital to securing resources but
also as an important social exchange that assisted with
powering innovation through gaining a broader consen-
sual base.
Reinvention [12] on the part of prospective adopters
was a common theme in that innovators expected
others to adapt and modify the innovation in the new
context thus increasing the likelihood of sustainable dif-
fusion. For those leading the development of new ser-
vices in healthcare settings, having an identity of
“successful innovator” was both feasible and desirable. It
was thus vital to the maintenance of that identity that
potential adopters in other healthcare organisations
should understand that the initiatives were highly con-
text-specific (see also [38]) and thus their active adop-
tion in new contexts all but constituted another
innovation.
Finally, our findings indicate the importance of a sup-
portive environment for the establishment and diffusion
of service innovation along with the technological
enablers, as this is proposed in the theory of disruptive
innovation [22,23]. The example of the multilateral
innovation around sustainability is informative: most of
the single initiatives within this innovation-green IT
developments, sustainable transportation scheme-reso-
nated with the broader spirit of environmentalism and
energy-saving policies and were implemented success-
fully. However there was a particular case-the construc-
tion of a sustainable food procurement unit-which, even
though it could bring significant cost-savings and was
consonant with the sustainability agenda adopted by the
Trust, was nevertheless severely impeded due to the
absence of a regulatory body within healthcare that
would align, support and coordinate the relevant
activities.
Limitations and strengths of the present study
One limitation of this research is its cross-sectional
design which precludes an examination of the underly-
ing processes of innovation initiation, implementation
and diffusion, as a longitudinal study would have done.
However, this study provided the unique insights and
experiences of healthcare innovators who had conceived
and led process-oriented innovations. Innovators can
contribute significantly in the diffusion of new initia-
tives, as they often appear willing to lead constructive
efforts of dissemination, operating as powerful cham-
pions. They are able to advise and indicate the most
promising ways of adoption and implementation, since
they carry valuable experience of their own efforts to
implement the initiative in their organisations. However
attention should be paid as to what stages of diffusion
innovators are more likely to contribute positively, since
high levels of champions’ identification with their role
or organisation may actually impede further innovation
diffusion [39]. On-going support of healthcare innova-
tors, especially in their attempts to promulgate and pub-
licise the novelty, is crucial for the dissemination of new
initiatives.
Conclusions
By interviewing key organisational representatives who
had developed and established a range of healthcare ser-
vice innovations from a variety of healthcare sectors we
attempted to understand the factors obstructing or facil-
itating the innovation implementation and diffusion. A
set of common determinants was identified across inter-
views pertaining to the availability of quantitative evi-
dence, the building of trustworthy partnerships, the
support from human resources, and the existence of a
favourable inner and outer context. Innovators repeat-
edly stressed the necessity of innovation adaptation if it
were to be implemented in a different context, suggest-
ing innovators’ awareness of the context-specific
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character of the innovations, and their desire to defend
an identity of successful innovator. Finally, the contribu-
tion of innovators to the promulgation and dissemina-
tion of the novel message beyond the boundaries of
their organisation may be beneficial in guiding and
advising prospective adopters in their own effort to
introduce change.
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